Asked by: Luke Murphy (Labour - Basingstoke)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the average waiting time at A&E in (a) Basingstoke and North Hampshire Hospital, (b) Hampshire and (c) England was in each of the last ten years.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The data is not available in the format requested. Official data on the total amount of time patients wait in accident and emergency is collected and published by NHS England. This information is published monthly, including by National Health Service trust, and is available at the following link:
https://www.england.nhs.uk/statistics/statistical-work-areas/ae-waiting-times-and-activity/
This information is also published annually, at the national level, and is available at the following link:
Asked by: Luke Murphy (Labour - Basingstoke)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make a comparative assessment of prostate cancer diagnosis rates in (a) Basingstoke, (b) Hampshire and (c) England.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
No comparative assessment has been made. However, data for prostate cancer diagnosis rates are collected by integrated care board (ICB), both Basingstoke and Hampshire are located within the Hampshire and Isle of White ICB. The following table shows this data up to 2022:
Stage at diagnosis | Count | Rate |
All stages | 2312 | 249.4 |
Stage 1 & 2 | 986 | 106 |
Stage 3 & 4 | 828 | 88.9 |
For comparison, the following table shows the national data for 2022:
Stage at diagnosis | Count | Rate |
All stages | 54732 | 212.4 |
Stage 1 & 2 | 21610 | 82.4 |
Stage 3 & 4 | 19042 | 74 |
The Department is supporting the National Health Service in taking steps to speed up and improve the efficiency of diagnostic pathways. This includes the introduction of a best-practice timed pathway for prostate cancer so that those suspected of having prostate cancer receive a multi-parametric magnetic resonance imaging scan first; this ensures only those men most at risk of having cancer undergo an invasive biopsy. For patients, the prostate best-practice timed pathway may reduce anxiety and uncertainty of a possible cancer diagnosis, with less time between referral and receiving the outcome of a diagnostic test.
Furthermore, NHS England’s Getting It Right First Time programme published guidance in April 2024 to support the implementation of good practice in management of prostate cancer, which includes ensuring the diagnostic pathways for prostate cancer were implemented from primary care setting to secondary care presentation.
Asked by: Luke Murphy (Labour - Basingstoke)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many new patients NHS dental practices in (a) Basingstoke constituency, (b) Hampshire and (c) England accepted in each of the last ten years.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
Data on the number of new patients seen since March 2024 as part of the New Patient Premium scheme will be published by NHS Business Services Authority (NHSBSA) in due course. This will be available at national as well as integrated care board (ICB) level. We do not hold historical data on the number of new patients seen.
The Government will tackle the immediate crisis with a rescue plan to provide 700,000 more urgent dental appointments and recruit new dentists to areas that need them most. To rebuild dentistry in the long term, we will reform the dental contract, with a shift to focus on prevention and the retention of National Health Service dentists.
NHS dentists are required to keep their NHS.UK profiles up to date so that patients can find a dentist more easily. This includes information on whether they are accepting new patients. This information is available at the following link:
https://www.nhs.uk/service-search/find-a-dentist
The responsibility for commissioning primary care services, including NHS dentistry, to meet the needs of the local population has been delegated to ICBs across England. For Basingstoke and Hampshire constituency, this is the NHS Hampshire and Isle of Wight ICB.
Asked by: Luke Murphy (Labour - Basingstoke)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the vacancy rate for GP roles in (a) Basingstoke constituency, (b) Hampshire and (c) England was in each of the last ten years.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The data requested is not held centrally.
Asked by: Luke Murphy (Labour - Basingstoke)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make a comparative assessment of waiting times for ADHD in (a) Hampshire and (b) other NHS Trusts in England.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
There is, at present, no single, established dataset that can be used to monitor waiting times for the assessment and diagnosis for attention deficit hyperactivity disorder (ADHD) either nationally, or for individual organisations or geographies in England. Although the data requested is not held centrally, it may be held locally by individual National Health Service trusts or commissioners.
We are supporting a taskforce that NHS England is establishing to look at ADHD service provision and its impact on patient experience. The taskforce will bring together expertise from across a broad range of sectors, including the NHS, education, and justice, to better understand the challenges affecting people with ADHD, and to help provide a joined-up approach in response to concerns around rising demand.
Alongside the work of the taskforce, NHS England will continue to develop a national ADHD data improvement plan, carry out more detailed work to understand the provider and commissioning landscape, and capture examples from local health systems which are trialling innovative ways of delivering ADHD services to ensure best practice is captured and shared across the system.
Asked by: Luke Murphy (Labour - Basingstoke)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps the Department is taking to reduce (a) the backlog of ADHD diagnosis and (b) improve waiting times for assessments.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Department is currently considering next steps to improve access to attention deficit hyperactivity disorder (ADHD) assessments. It is the responsibility of integrated care boards to make appropriate provision to meet the health and care needs of their local population, including ADHD assessments, in line with relevant National Institute for Health and Care Excellence guidelines.
We are supporting a taskforce that NHS England is establishing to look at ADHD service provision and its impact on patient experience. The taskforce will bring together expertise from across a broad range of sectors, including the National Health Service, education, and justice, to better understand the challenges affecting people with ADHD and to help provide a joined-up approach in response to concerns around rising demand.
Alongside the work of the taskforce, NHS England will continue to develop a national ADHD data improvement plan, carry out more detailed work to understand the provider and commissioning landscape, and capture examples from local health systems which are trialling innovative ways of delivering ADHD services to ensure best practice is captured and shared across the system.
Asked by: Luke Murphy (Labour - Basingstoke)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve diagnosis of Chronic Kidney Disease for (a) younger patients and (b) broadly.
Answered by Andrew Gwynne
NHS England is working to detect people at risk of kidney disease through the NHS Health Check Programme. The programme, which is available for everyone between the ages of 40 and 74 years old, who is not already on a chronic disease register, assesses people’s health and risk of developing certain health problems. Using this information, patients are supported to make behavioural changes and access treatment which helps to prevent and detect kidney disease earlier.
NHS England has established the Renal Services Transformation Programme (RSTP), which aims to reduce unwarranted variation in the quality and accessibility of renal care, to improve outcomes and services for those with kidney disease. NHS England, through the RSTP and regional renal networks, is implementing initiatives to provide better, integrated care, to reduce health inequalities, and to focus on prevention and timely intervention for kidney disease.
Working in collaboration with the NHS RightCare Programme and the renal community, the RSTP has developed a renal toolkit to provide integrated care boards, renal clinical networks, and providers with tools, case studies, and principles to support transformation of services at a local level. The toolkit outlines principles to support better management of patients identified with chronic kidney disease (CKD) throughout their patient journey. The RSTP is also working closely with NHS England’s regional renal clinical networks to review this toolkit, and to work with local partners to develop transformation programmes that will focus on early identification and management of kidney disease, and will seek to reduce the number of patients progressing through various stages of CKD, and reduce the number of patients requiring dialysis. By supporting prevention and early intervention, the need for late-stage treatments will be reduced.
Regional renal clinical networks prioritise the prevention and early diagnosis of CKD within their transformation ambitions. This includes considerations to develop a unified approach to testing populations at risk of developing CKD, and includes raising awareness of diagnostic tools like urine albumin creatinine tests, enabling CKD diagnosis at stages 1 and 2. NHS England aims to improve awareness and access to these important urine and blood tests across primary and secondary care.
The National Institute for Health and Care Excellence’s guidance, Chronic kidney disease: Assessment and management [NG203], updated in November 2021, sets out best practice for clinicians in the diagnosis and management of CKD. The guidance covers the care and treatment of patients at risk of CKD. It includes recommendations on the monitoring of patients at risk of CKD, and aims to prevent or delay the progression of the disease. The guidance is available at the following link:
https://www.nice.org.uk/guidance/ng203
Asked by: Luke Murphy (Labour - Basingstoke)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve treatment of Chronic Kidney Disease.
Answered by Andrew Gwynne
NHS England is working to detect people at risk of kidney disease through the NHS Health Check Programme. The programme, which is available for everyone between the ages of 40 and 74 years old, who is not already on a chronic disease register, assesses people’s health and risk of developing certain health problems. Using this information, patients are supported to make behavioural changes and access treatment which helps to prevent and detect kidney disease earlier.
NHS England has established the Renal Services Transformation Programme (RSTP), which aims to reduce unwarranted variation in the quality and accessibility of renal care, to improve outcomes and services for those with kidney disease. NHS England, through the RSTP and regional renal networks, is implementing initiatives to provide better, integrated care, to reduce health inequalities, and to focus on prevention and timely intervention for kidney disease.
Working in collaboration with the NHS RightCare Programme and the renal community, the RSTP has developed a renal toolkit to provide integrated care boards, renal clinical networks, and providers with tools, case studies, and principles to support transformation of services at a local level. The toolkit outlines principles to support better management of patients identified with chronic kidney disease (CKD) throughout their patient journey. The RSTP is also working closely with NHS England’s regional renal clinical networks to review this toolkit, and to work with local partners to develop transformation programmes that will focus on early identification and management of kidney disease, and will seek to reduce the number of patients progressing through various stages of CKD, and reduce the number of patients requiring dialysis. By supporting prevention and early intervention, the need for late-stage treatments will be reduced.
Regional renal clinical networks prioritise the prevention and early diagnosis of CKD within their transformation ambitions. This includes considerations to develop a unified approach to testing populations at risk of developing CKD, and includes raising awareness of diagnostic tools like urine albumin creatinine tests, enabling CKD diagnosis at stages 1 and 2. NHS England aims to improve awareness and access to these important urine and blood tests across primary and secondary care.
The National Institute for Health and Care Excellence’s guidance, Chronic kidney disease: Assessment and management [NG203], updated in November 2021, sets out best practice for clinicians in the diagnosis and management of CKD. The guidance covers the care and treatment of patients at risk of CKD. It includes recommendations on the monitoring of patients at risk of CKD, and aims to prevent or delay the progression of the disease. The guidance is available at the following link:
https://www.nice.org.uk/guidance/ng203
Asked by: Luke Murphy (Labour - Basingstoke)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much funding the Hampshire Hospitals scheme received to the end of the 2023-24 financial year.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
I refer the hon. Member to the answer I gave on 29 October 2024 to Question 10950.
Asked by: Luke Murphy (Labour - Basingstoke)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the (a) business case status and (b) RIBA stage is for the Hampshire Hospitals scheme as part of the New Hospital Programme.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The standard process confirming the total funding amount for major infrastructure projects involves the review and approval of a Full Business Case. All trusts in the programme have previously received indicative funding allocations to support planning, however these are commercially sensitive.
Up to the end of the 2023/24, the total amount received by the Hampshire Hospitals NHS Foundation Trust in funding for their new hospital schemes is £8.5 million.
The breakdown of how much the trust received for their new hospital scheme is published annually as part of the Department’s Annual Reports and Accounts, with Public Dividend Capital to individual trusts included in the Financial Assistance Report under section 40 of the National Health Service Act 2006. The 2022/23 report is available at the following link:
https://www.gov.uk/government/publications/dhsc-annual-report-and-accounts-2022-to-2023
The trust is currently developing their Outline Business Case for the Hampshire Hospitals scheme and is at Royal Institute of British Architects Stage 0.